000 | 02268 a2200601 4500 | ||
---|---|---|---|
005 | 20250514232146.0 | ||
264 | 0 | _c20060818 | |
008 | 200608s 0 0 eng d | ||
022 | _a1540-658X | ||
024 | 7 |
_a10.1089/adt.2005.3.273 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHardcastle, Anthea | |
245 | 0 | 0 |
_aSolid-phase immunoassays in mechanism-based drug discovery: their application in the development of inhibitors of the molecular chaperone heat-shock protein 90. _h[electronic resource] |
260 |
_bAssay and drug development technologies _cJun 2005 |
||
300 |
_a273-85 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBenzoquinones |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aCell Extracts _xanalysis |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHCT116 Cells |
650 | 0 | 4 |
_aHSP70 Heat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHT29 Cells |
650 | 0 | 4 |
_aHeterocyclic Compounds, 2-Ring _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoassay _xmethods |
650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
650 | 0 | 4 | _aLactams, Macrocyclic |
650 | 0 | 4 |
_aLymphocytes _xchemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-raf _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 |
_aQuinones _xpharmacology |
650 | 0 | 4 |
_aRifabutin _xanalogs & derivatives |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 | _aTransplantation, Heterologous |
650 | 0 | 4 |
_aeIF-2 Kinase _xantagonists & inhibitors |
700 | 1 | _aBoxall, Kathy | |
700 | 1 | _aRichards, Juliet | |
700 | 1 | _aTomlin, Peter | |
700 | 1 | _aSharp, Swee | |
700 | 1 | _aClarke, Paul | |
700 | 1 | _aWorkman, Paul | |
700 | 1 | _aAherne, Wynne | |
773 | 0 |
_tAssay and drug development technologies _gvol. 3 _gno. 3 _gp. 273-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/adt.2005.3.273 _zAvailable from publisher's website |
999 |
_c15630109 _d15630109 |